diosgenin has been researched along with Insulin Resistance in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X; Jin, Y; Liu, KX; Peng, JY; Qi, Y; Xu, LN; Xu, YW; Yin, LH; Zhao, YY | 1 |
| Gan, Q; Hu, J; Huang, Q; Lou, G; Peng, C; Wang, J; Xiong, H; Zheng, S | 1 |
| Li, H; Yu, L; Zhao, C | 1 |
| Badale, A; Cziáky, Z; Hegedűs, C; Kiss, R; Kovács, D; Máthé, E; Pesti-Asbóth, G; Remenyik, J; Stündl, L; Szarvas, MM; Szilvássy, Z | 1 |
| Begum, MS; Meriga, B; Mohan, K; Naidu, PB; Ponmurugan, P; RavindarNaik, R; Saravanan, G | 1 |
| Hai, C; Liu, J; Liu, Y; Long, Z; Sun, Q; Wang, L; Wang, X; Zhang, X | 1 |
| Goto, T; Hirai, S; Hoshino, S; Kawada, T; Lee, JY; Mizoguchi, N; Nakano, Y; Narukami, T; Shono, J; Takahashi, N; Taketani, K; Tsuge, N; Uemura, T | 1 |
| Gao, X; Huang, F; Kou, J; Liu, B; Liu, K; Zhao, W | 1 |
1 review(s) available for diosgenin and Insulin Resistance
| Article | Year |
|---|---|
The role of diosgenin in diabetes and diabetic complications.
Topics: Animals; Apoptosis; Diabetes Complications; Diabetes Mellitus; Diosgenin; Female; Glycolipids; Hep G2 Cells; Humans; Hypoglycemia; Inflammation; Insulin; Insulin Resistance; Male; Mice; Oxidative Stress; Plants; Rabbits; Rats; Steroids | 2020 |
7 other study(ies) available for diosgenin and Insulin Resistance
| Article | Year |
|---|---|
Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Diosgenin; Gene Expression Regulation; Gluconeogenesis; Glycolipids; Hep G2 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipogenesis; Liver; Male; Mice, Inbred C57BL; MicroRNAs; Rats, Wistar; STAT3 Transcription Factor | 2020 |
Dioscin attenuates high‑fat diet‑induced insulin resistance of adipose tissue through the IRS‑1/PI3K/Akt signaling pathway.
Topics: Adipose Tissue; Adiposity; Animals; Blood Glucose; Diet, High-Fat; Diosgenin; Glucose; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2019 |
Diosgenin and Its Fenugreek Based Biological Matrix Affect Insulin Resistance and Anabolic Hormones in a Rat Based Insulin Resistance Model.
Topics: Administration, Oral; Animals; Diet, High-Fat; Diosgenin; Glucose; Growth Hormone; Herbal Medicine; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Male; Models, Animal; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Thyroid Hormones; Trigonella | 2019 |
Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Dietary Fats; Diosgenin; Dyslipidemias; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Male; Phytotherapy; Plant Extracts; Rats, Wistar; Trigonella; Weight Gain | 2015 |
Effect of diosgenin on metabolic dysfunction: Role of ERβ in the regulation of PPARγ.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adipose Tissue; Adiposity; Animals; Biomarkers; Blood Glucose; Diet, High-Fat; Diosgenin; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogen Receptor beta; Insulin; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; PPAR gamma; Reactive Oxygen Species; Retinoid X Receptor alpha; Signal Transduction; Time Factors | 2015 |
Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Blood Glucose; Cell Differentiation; Diosgenin; Disease Models, Animal; Glucose; Inflammation; Insulin Resistance; Male; Mice; Mice, Obese; Obesity; Phytotherapy; Plant Extracts; RNA, Messenger; Saponins; Trigonella | 2010 |
Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; Diosgenin; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; Inflammation Mediators; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; Microscopy, Fluorescence; Nitric Oxide; Nitric Oxide Synthase Type III; Palmitic Acid; Phosphorylation; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Salicylic Acid; Signal Transduction; Tumor Necrosis Factor-alpha; Vasodilation | 2012 |